Ark Surgical

Company Overview

Snapshot

Founded in June 2017 by Zohar Gendler, Stav Tori, Aaron Feldman, Abraham Yaari, and Nizar Mishael, Ark Surgical operates with 11–50 employees. The company has raised $7.11M across 15 funding rounds from 2 investors. In April 2025, Ark Surgical secured FDA 510(k) clearance for LapBox® POWER, its second FDA-cleared device, marking a significant regulatory and product development milestone.

Business overview

Ark Surgical is a commercial-stage medical device company dedicated to advancing women’s health through safer, smarter surgical solutions. The company develops and offers two FDA-cleared devices, including its flagship product, LapBox, a containment system designed for minimally invasive and robotic gynecologic surgeries. This technology prevents the spread of cancerous or endometrial tissue, addressing a critical unmet need identified by the FDA. Ark Surgical's solutions empower gynecologic surgeons to optimize patient safety and outcomes while helping hospitals comply with FDA standards for tissue containment, operating within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices industry.

Strategic signal

In April 2025, Ark Surgical received FDA 510(k) clearance for LapBox® POWER, its second FDA-cleared device. This regulatory approval for a dual-wall system for contained morcellation validates the company's innovation in women's health and its commitment to patient safety. For investors, this signals strong product development capabilities and a clear path to market expansion within the medical device industry, particularly in gynecological surgery.

Company Intelligence Q&A

What is Ark Surgical's primary focus?

Ark Surgical is a commercial-stage medical device company focused on advancing women’s health through safer, smarter surgical solutions, with two FDA-cleared devices.

When did Ark Surgical receive FDA clearance for LapBox® POWER?

In April 2025, Ark Surgical secured FDA 510(k) clearance for LapBox® POWER, a dual-wall system for contained morcellation.

What is LapBox?

LapBox is Ark Surgical's flagship product, a first-of-its-kind containment system that enables minimally invasive and robotic gynecologic surgeries while preventing the spread of cancerous or endometrial tissue.

How much capital has Ark Surgical raised?

Ark Surgical has raised a total of $7.11M across 15 funding rounds.

When did Ark Surgical perform its first hysterectomies in the USA with LapBox?

In November 2023, Ark Surgical performed its first hysterectomies in the USA using its FDA-cleared LapBox for manual morcellation.